Bionto – 4M€ Capital Raising
Grannenfelt Finance acted as the financial advisor to Bionto Oy in their 4M€ capital raising process.
Grannenfelt Finance acted as the financial advisor to Bionto Oy in their 4M€ capital raising process.
Grannenfelt Finance acted as the financial advisor to Bionto Oy in their 4M€ capital raising process. The solo investor in the round was Finnish Family Office Korpi Capital.
BIONTO provides its clients with an industrial production platform covering the entire biosolution development process from concept to industrial production.
Throughout the process, Grannenfelt Finance held investor discussions with all the relevant biotech VC and corporate investors providing the Client a very holistic view of the capital market opportunities.
Funding Strategy: Developed a comprehensive financing strategy that considers various sources of funding.
Material Preparation: Designed and prepared marketing materials and strategies for investors.
Investor Contact: Identified, evaluated, and engaged with potential investors.
Due Diligence and Negotiations: Assisted Bionto throughout the due diligence process, negotiations, and the successful closing of the financing round.
For more information about Bionto, visit their website here.
"Grannenfelt Finance played a key role in supporting Bionto Ltd, a provider of end-to-end biosolutions for the industry, to secure €4 million in funding from Finnish family office Korpi Capital. Their process was professional and efficient, leading to a successful outcome."
Grannenfelt Finance acted as the financial advisor to Hycamite TCD Technologies Oy in their 25M€ ...
Sensative provides a unified, smart & agile infrastructure platform that seamlessly enables ...
RGNT Motorcycles is a premium electric motorcycle manufacturer based in the Swedish automotive ...
The European Investment Bank (EIB) has signed a quasi-equity agreement worth €20 million with ...
Vaadin is a Finnish-based company that was founded in 2000. Their main product is the “Vaadin ...
Leave your contact details to keep up to date with the latest funding and M&A news.